清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

Management of Hemangioma of Infancy: Review of 245 Patients

医学 头颈部 后备箱 血管瘤 外科 回顾性队列研究 B组 儿科 生态学 生物
作者
Bruce M. Achauer,Chang Chen,Victoria M. Vander Kam
出处
期刊:Plastic and Reconstructive Surgery [Ovid Technologies (Wolters Kluwer)]
卷期号:99: 1301-1308 被引量:132
标识
DOI:10.1097/00006534-199704001-00014
摘要

A retrospective study of patients treated from May of 1981 to April of 1994 was conducted. A total of 245 patients with 299 hemangiomas were studied, which represents the largest series reported to date. The study consisted of 173 females and 72 males ranging in age from 1 day to 59 years, with the average age being 4 years and 7 months. Twenty-six were premature neonates (14 females and 12 males). An interesting finding was a 1:1 sex ratio among this group in contrast to the 3:1 female-male ratio frequently reported in the literature. Onset was at birth in 170, within the first month in 43, and after the age of 1 month in 32 patients. Among the 245 patients, 175 hemangiomas were located on the head and neck, 62 on the trunk, 49 on the extremities, and 13 in the perineal area. Five groups of patients were defined based on clinical management. As a result, these groups are not similar. The five groups are as follows: group I (48), observation; group II(9), steroid treatment; group III (27), excision and reconstruction; group IV(88), laser therapy; and group V (73), combined therapy. The involved area of hemangioma was as follows: group 1, 0.5 × 0.5 to 20 × 8 cm; group II, 2 × 2 to 8 × 8 cm; group III, 0.4 × 0.8 to 7 × 7 cm; group IV, 0.5 × 0.5 to 20 × 9 cm; and group V, 1.5 × 1.5 to 25 × 25 cm. The complications of hemangioma seen at the time of consultation were obstruction (28.6 percent), ulceration (20.4 percent), bleeding (14.7 percent), infection (4.9 percent), and pain (0.4 percent). Treatment periods ranged from 1 month to 11 years, with the mean period in each group as follows: group I, 4 years and 9 months; group II, 2 years and 5 months; group III, 1 year and 1 month; group IV, 2 years and 1 month; and group V, 3 years. The outcomes of each patient were evaluated based on improvement of volume, color, and texture by the following scale: 1, poor (0 to 25 percent); 2, fair (26 to 50 percent); 3, good (51 to 75 percent); and 4, excellent (76 to 100 percent). Each of these parameters was summarized for each of the five groups. Statistical analysis by the Irwin-Fisher test was used for analysis and comparison of the final results between groups. Statistically significant differences in outcomes between treatment groups were demonstrated. Laser therapy was shown to be statistically superior to observation with regard to length of treatment and with regard to outcomes of volume and texture (p < 0.05).
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
muriel完成签到,获得积分10
4秒前
11秒前
20秒前
44秒前
研友_Ljqal8完成签到,获得积分10
1分钟前
vbnn完成签到 ,获得积分10
1分钟前
zxr完成签到 ,获得积分10
1分钟前
应夏山完成签到 ,获得积分10
1分钟前
名侦探柯基完成签到 ,获得积分10
1分钟前
2分钟前
lalala发布了新的文献求助10
3分钟前
爱静静应助科研通管家采纳,获得10
4分钟前
爱静静应助科研通管家采纳,获得10
4分钟前
4分钟前
Outsider完成签到,获得积分10
4分钟前
5分钟前
土豪的灵竹完成签到 ,获得积分10
5分钟前
5分钟前
喜悦的飞飞完成签到,获得积分10
5分钟前
lalala发布了新的文献求助10
5分钟前
6分钟前
科研通AI2S应助科研通管家采纳,获得10
6分钟前
酷波er应助Kevin采纳,获得10
6分钟前
6分钟前
6分钟前
lalala发布了新的文献求助10
6分钟前
7分钟前
7分钟前
7分钟前
8分钟前
爱静静应助科研通管家采纳,获得10
8分钟前
爱静静应助科研通管家采纳,获得10
8分钟前
爱静静应助科研通管家采纳,获得10
8分钟前
爱静静应助科研通管家采纳,获得10
8分钟前
爱静静应助科研通管家采纳,获得10
8分钟前
爱静静应助科研通管家采纳,获得10
8分钟前
Kevin发布了新的文献求助10
8分钟前
lilili完成签到,获得积分10
8分钟前
puzhongjiMiQ发布了新的文献求助10
8分钟前
puzhongjiMiQ完成签到,获得积分10
8分钟前
高分求助中
Lire en communiste 1000
Ore genesis in the Zambian Copperbelt with particular reference to the northern sector of the Chambishi basin 800
Mantiden: Faszinierende Lauerjäger Faszinierende Lauerjäger 700
PraxisRatgeber: Mantiden: Faszinierende Lauerjäger 700
Becoming: An Introduction to Jung's Concept of Individuation 600
肝病学名词 500
Evolution 3rd edition 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3171584
求助须知:如何正确求助?哪些是违规求助? 2822457
关于积分的说明 7939252
捐赠科研通 2483077
什么是DOI,文献DOI怎么找? 1322962
科研通“疑难数据库(出版商)”最低求助积分说明 633826
版权声明 602647